EGFR and laryngotracheoesophageal cleft: Among the Chinese ERBB2ΔEx16+ patients, 12 had EGFR-positive LC and had been previously treated with EGFR TKI(s), accounting for 0.068% of the patients carrying EGFR sensitizing mutations (n = 17753).